GlassScriptPhysician profile
Onelio Garcia
NPI 1861502353
$79,354.18
in general payments reported to CMS, 2019-2025
26 companies · $14K in 2025
The $14K reported for 2025 was more than what 96% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,737 · 2020: $12K · 2021: $9,952 · 2022: $23K · 2023: $5,160 · 2024: $12K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Food and Beverage: $7,017 · Honoraria: $1,500 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000 · Travel and Lodging: $689.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,910.00 |
| Food and Beverage | $7,017.24 |
| Honoraria | $1,500.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
| Travel and Lodging | $689.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solta Medical, A Division of Bausch Health US, LLC | $31,094.83 | 2021-2025 | Clear+Brilliant |
| Davol INC. | $16,914.21 | 2020-2025 | Phasix Mesh, Arista Ah Flexitip, Avitene Ultrafoam |
| Musculoskeletal Transplant Foundation INC. | $9,257.87 | 2019-2025 | |
| Mentor Worldwide LLC | $4,776.55 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander, Mentor Siltex Round Spectrum |
| Medical Device Business Services, INC. | $4,000.00 | 2020 | |
| Motiva USA, LLC | $3,370.23 | 2024-2025 | |
| Tepha INC | $2,048.42 | 2019-2020 | |
| Sientra, INC. | $1,685.34 | 2019-2022 | |
| Bimini Technologies LLC | $1,500.00 | 2025 | |
| Abbvie INC. | $708.35 | 2023-2025 | |
| Remel, INC. | $640.62 | 2022 | |
| Allergan, INC. | $530.97 | 2019-2022 | |
| Becton, Dickinson and Company | $487.77 | 2022-2025 | Galaflex, Phasix Mesh |
| Galderma Laboratories, L.P. | $460.86 | 2020-2024 | |
| Stryker Corporation | $322.20 | 2023-2024 | Spy-Phi System |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $254.63 | 2019-2023 | Durasorb Monofilament Mesh |
| Axogen | $228.59 | 2019-2023 | Avance Nerve Graft |
| Checkpoint Surgical, INC | $167.07 | 2020 | |
| Smith+Nephew, INC. | $144.32 | 2025 | Renasys Touch, Pico 14 |
| Kerecis Limited | $131.01 | 2021-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Ethicon US, LLC | $130.13 | 2019 | |
| Medline Industries LP | $124.48 | 2020 | |
| Melinta Therapeutics, LLC | $121.87 | 2019 | |
| Tela Bio, INC. | $117.97 | 2020 | |
| Zimmer Biomet Holdings, INC. | $108.67 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $27.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Onelio Garcia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.